Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 -0.06 (-0.62%)
As of: Oct 22, 2026 · 11:12 AM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Long-Term Debt Issuances (2021 - 2026)

Updated

Aspire Biopharma Holdings' Long-Term Debt Issuances came in at $2 million for Q1 2026, down 33.3% from $3 million a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Long-Term Debt Issuances (2021 - 2026) Analysis & Trends

For FY2025, Aspire Biopharma Holdings' Long-Term Debt Issuances was $10.25 million.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of 156.0% (FY2021 to FY2025).
  • Going back by year, Long-Term Debt Issuances was $343,367 in FY2024 (+120.3%), $155,848 in FY2023 and $238,596 in FY2021.
  • The Q1 2026 figure represents the lowest quarterly Long-Term Debt Issuances since Q1 2024.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 2.00 Mn
Sep 30, 2025 7.25 Mn
Mar 31, 2025 3.05 Mn
Mar 31, 2024 264,027.00
Dec 31, 2021 25,870.00
Sep 30, 2021 181,811.00
API Access

Aspire Biopharma Holdings, Inc. Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=ASBP&period=max&api_key=YOUR_API_KEY